Publications

Return to Profile page 

Publications for last 10 years only 

2013

Burton JO, Hamali HA, Singh R, Abbasian N, Parsons R, Patel AK, Goodall AH, Brunskill NJ. Elevated levels of procoagulant plasma microvesicles in dialysis patients. PLoS One. 2013;8:e72663.

Batool S, Abbasian N, Burton JO, Stover C. Microparticles and their roles in inflammation: A Review. The Open Immunology Journal. 2013;6:1-14.

Breidthardt T, Burton JO, Odudu A, Eldehni MT, Jefferies H, McIntyre CW. N-terminal Pro-B-type natriuretic peptide and its correlation to haemodialysis-induced myocardial stunning. Nephron Clin Pract. 2013;123:118-22.

Dungey M, Hull KL, Smith AC, Burton JO, Bishop NC. Inflammatory factors and exercise in chronic kidney disease. Int J Endocrinol. 2013;2013:569831.

2012

Burton JO, Dormer JP, Binns HE, Pickering WP. Sometimes when you hear hoof beats it could be a zebra: consider the diagnosis of Fabry disease. BMC Nephrol 2012;13:73

Breidhardt T, Burton JO, Odudu A Eldehni MT, Jefferies HJ, McIntyre CW. Tropinin T for the detection of dialysis-induced myocardial stunning in haemodialysis patients. Clin J Am Soc Nephrol. 2012;7:1285-92.

Burton JO, Corry SJ, Lewis G, Priestman WS. Differences in medical care usage between two mass-gathering sporting events. Prehosp Disaster Med 2012;27:1-5

Harrison LE, Burton JO, Szeto CC, Li PK, McIntyre CW. Endotoxaemia in haemodialysis: a novel factor in erythropoeitin resistance? PLoS One 2012;7(6):e-40209

Burton JO, Gray LJ, Webb DR, Davies MJ, Khunti K, Crasto W, Carr SJ, Brunskill NJ. Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population. Nephrol Dial Transplant 2012;27:1860-6

Smith AC, Burton JO. Exercise in kidney disease and diabetes: time for action. J Ren Care 2012;38(s1):52-8.

2011

Eyre J, Burton JO, Saleem MA, Mathieson PW, Topham PS, Brunskill NJ. Monocyte and endothelial derived microparticles induce an inflammatory phenotype in human podocytes. Nephron Exp Nephrol 2011;119:e58-e66 (joint first author).

Jefferies HJ, Burton JO, McIntyre CW. Individualised dialysate temperature improves intradialytic haemodynamics and abrogates haemodialysis-induced myocardial stunning, without compromising tolerability. Blood Purif 2011;32:63-8

McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S, Owen PJ, Lai KB, Li PK. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 2011;6:133-41

2010

McIntyre NJ, Chesterton LJ, Joh SG, Jefferies HJ, Burton JO, Taal MW, Fluck RJ, McIntyre CW. Tissue-advanced glycation end product concentration in dialysis patients. Clin J Am Soc Nephrol 2010;5(1):51-5

Chesterton LJ, Selby NM, Burton JO, Fialova J, Chan C, McIntyre CW. Categorization of the hemodynamic response to hemodialysis: the importance of the baroflex sensitivity. Hemodial Int 2010;14(1):18-28

2009

Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function Clin J Am Soc Nephrol 2009;4(12):1925-31

Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Haemodialysis-induced cardiac injury: determinants and asociated outcomes. Clin J Am Soc Nephrol 2009;4(5):914-20

McIntyre CW, Burton JO. The management of intradialytic hypotension. Brit J Ren Med 2009;14:8-11

Korsheed S, Burton JO, McIntyre CW. Higher atreriovenous fistulae blood flows are associated with a lower level of dialysis-induced cardiac injury. Hemodial Int 2009;13(4):5050-11

Hothi DK, Rees L, Marek J, Burton JO, McIntyre CW. Pediatric myocardial stunning underscores the cardiac toxicity of conventional hemodialysis treatments. Clin J Am Soc Nephrol 2009;4(4):790-7

Chesterton LJ, Selby NM, Burton JO, McIntyre CW. Cool dialysate reduces asymptomatic intradialytic hypotension and increases baroreflex variability. Hemodial Int 2009;13(2):189-96.

2008

Burton JO, Korsheed S, Grundy BJ, McIntyre CW. Haemodialysis induced cardiac dysfunction is associated with an increase in ventricular arrhythmias. Ren Fail 2008;30(7):701-9.

McIntyre CW, Burton JO, Selby NM, Leccisotti L, Korsheed S, Baker CS, Camici PG. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 2008;3(1):19-26.

2002-2007

McIntyre CW, Burton JO. ABC of Renal Disease, Chapter 10. 1st Ed BMJ Books 2007.

Selby NM, Fialova J, Burton JO, McIntyre CW. The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids. Nephrol Dial Transplant 2007;22(3):870-9.

Selby NM, Burton JO, Chesterton LJ, McIntyre CW. Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol 2006;1(6):1216-25.

Burton JO, Lee D, Somayajula S, Patel V. Eruptive xanthomata in uncontrolled diabetes. Br J Diabetes Vasc Dis 2002;2:60-61.

Share this page: